Nuclear Medicine: Page 208

Choline-PET/CT changes prostate cancer treatment plans

By Wayne Forrest

Swiss researchers have found that PET/CT scans with the radiopharmaceutical choline can change treatment plans for certain patients with recurrent prostate cancer. Study results showed that choline-PET/CT significantly affected therapy management.

February 9, 2012

TC3 expands scientific council

By AuntMinnie.com staff writers

Cardiovascular imaging core laboratory TC3 has added Dr. Daniel Berman, Dr. John Friedman, and Guido Germano, PhD, to its scientific council.

February 8, 2012

Siemens brings Biograph mMR to Canada

By AuntMinnie.com staff writers

Siemens Healthcare has installed its Biograph mMR whole-body PET/MRI scanner at St. Joseph's Hospital in London, Ontario.

February 7, 2012

Zecotek partners with NuCare on PET scanner

By AuntMinnie.com staff writers

Nuclear medicine firm Zecotek Photonics has signed a joint development agreement with NuCare Medical Systems for a PET scanner using Zecotek's lutetium fine silicate (LFS) scintillation crystals, solid-state photo detectors based on the company's Micropixel Avalanche Photodiode (MAPD) technology, and a new data acquisition board and readout system.

February 7, 2012

FES-PET detects estrogen-receptor-positive breast cancer

By Wayne Forrest

Dutch researchers have concluded that whole-body PET with fluorine-18 fluoroestradiol (F-18 FES) can be a useful diagnostic tool in estrogen-receptor-positive breast cancer patients, according to a study published in the February issue of the Journal of Nuclear Medicine.

February 7, 2012

GE Hitachi puts molybdenum-99 project on ice

By Wayne Forrest

More than two years after the U.S. Department of Energy selected GE Hitachi Nuclear Energy to develop a new technology for producing the radioisotope molybdenum-99, the company has decided not to proceed with the project, saying it is not economically feasible at this time.

February 6, 2012

Positron signs Sr-82 deal with Russian firm

By AuntMinnie.com staff writers

Manhattan Isotope Technology, a subsidiary of PET developer Positron, has signed an agreement with the Institute for Nuclear Research of Troitsk, Russia, to collaborate on the production of strontium-82 (Sr-82).

February 6, 2012

PET aids tough breast cancer cases

By AuntMinnie.com staff writers

PET imaging with FDG and a radiopharmaceutical that targets estrogen receptors can help physicians gather more information in difficult breast cancer cases, according to two studies in the February issue of the Journal of Nuclear Medicine.

February 6, 2012

Dana-Farber nets cancer imaging research grant

By AuntMinnie.com staff writers

The Massachusetts Life Sciences Center has awarded Dana-Farber Cancer Institute a $10 million grant to support the expansion of its cancer imaging research program.

February 5, 2012

Tomayko buys stake in CardioLogic

By AuntMinnie.com staff writers

The Tomayko Group has acquired a majority ownership stake in CardioLogic, a nuclear cardiology management firm based in Bala Cynwyd, PA.

February 2, 2012

CardioGen-82 recall officially ends

By AuntMinnie.com staff writers

Bracco Diagnostics' recall of its CardioGen-82 cardiac PET radiopharmaceutical is officially over.

February 2, 2012

PET after radiation therapy predicts NSCLC survival

By Wayne Forrest

PET can provide strong indicators of overall and disease-free survival among patients with locally advanced non-small cell lung cancer (NSCLC) receiving radiation therapy, according to a study published in the February Journal of Nuclear Medicine.

February 2, 2012

Previous Page

Page 208 of 440

Next Page